VSee Health, Inc. (VSEE) Stock Price & Analysis
VSee Health, Inc. (VSEE) — price $0.21 (+5.26%), as of the Nov 19, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
VSee Health, Inc. · VSEE
VSee Health, Inc. provides specialized telehealth solutions, primarily focusing on iDoc Telehealth for acutely ill patients in neurointensive, cardiac intensive, and general intensive care units. The company offers a HIPAA-compliant platform designed to treat and coordinate care for complex neurological and cardiac conditions.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.21 | |
| Change on the day | +5.26% | |
| 52-week range | $0.005 – $3.50 | |
| Shares traded on the day | 25.0K |
Price & events
Other perspectives
Council score for VSee Health (VSEE): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
4 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is VSee Health (VSEE), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. VSee Health, Inc. (VSEE) is the company analyzed here. It employs 209 people and is led by Imoigele Aisiku. In Q2 FY2026 it reported revenue of $2M and net income of -$3M.
What do the latest results show for VSee Health (VSEE)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $2M. Against analyst estimates the company has EPS beat 4 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $2M | -$3M | -$4.59 (diluted) |
| Q1 FY2026 | $3M | -$3M | -$4.00 (diluted) |
| Q4 FY2025 | $4M | -$8M | -$24.80 (diluted) |
| Q3 FY2025 | $4M | -$289,745 | -$1.40 (diluted) |
What are the financial strengths and risks for VSee Health (VSEE)?
Short answer · as of
The distress and quality screens read Altman Z -8.92 · Piotroski F 3. Trailing ratios: ROA -82.6% · current ratio 0.40.
Data-derived red flags
- Financial-distress signal — its Altman Z-Score of -8.92 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
The records behind this page
Insider activity
Form 4 records via FMP · Most recent available transactions
- Transactions
- 12
- Identified insiders
- 6
- Purchases
- 0
- Sales
- 0
- Other transactions
- 12
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held VSEE in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported VSEE in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What Investors Ask About VSee Health (VSEE)
These answers are editorial: 1 of these 8 answers is drawn from the VSEE research dossier (written Jun 15, 2026 by gemini-2.5-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is VSEE a good stock to buy?
Stock Expert AI does not rate VSEE buy, sell or hold. VSee Health, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the VSEE stock price today?
The last price recorded for VSee Health, Inc. (VSEE), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What does VSee Health, Inc. do?
VSee Health, Inc. specializes in providing telehealth care solutions, with a particular focus on high-acuity medical environments. The company's flagship offering, iDoc Telehealth solutions, is designed to facilitate the treatment and coordinated care for acutely ill patients in critical settings such as neurointensive care units (NICU), cardiac intensive care units (CICU), and general intensive care units (ICU).
What are the key factors to evaluate for VSEE?
Evaluate VSEE on fundamentals, analyst consensus, and risk factors. The demand for secure healthcare IT solutions is ongoing and will remain a critical growth driver for the foreseeable future. Not financial advice.
How frequently does VSEE data refresh on this page?
VSEE's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven VSEE's recent stock price performance?
VSee Health, Inc. (VSEE) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized focus on iDoc Telehealth for acutely ill patients in critical care units (NICU, CICU). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider VSEE overvalued or undervalued right now?
VSee Health, Inc. (VSEE) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research VSEE before investing?
Before investing in VSee Health, Inc. (VSEE), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 14 figures on this page — 8 from Financial Modeling Prep (FMP) and 6 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com